Acupuncture Therapy VS Chiropractor Group Therapy to Reduce Anxiety and Depression.

HIV/AIDS Clinical Trial

Official title:

A Controlled Clinical Trial of Group Acupuncture Therapy VS Chiropractor Group Therapy to Reduce Anxiety and Depression in People Living With HIV/AIDS (PLWH/A).

Clinical Trial Details — Status: Enrolling by invitation

Administrative data

• NCT number: NCT05936905
• Other study ID #: YSU8232022
• Status: Enrolling by invitation
• Phase: N/A
• Start date: July 6, 2023
• Est. completion date: February 1, 2024

Study information

• Verified date: July 2023
• Source: Yo San University of Traditional Chinese Medicine
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study aims to determine and compare acupuncture therapy and chiropractor group therapy to reduce anxiety and depression among HIV/AIDS patients at Being Alive, Los Angeles. In this controlled clinical trial, a total of 30 patients will be divided into two groups, 15 in the acupuncture therapy group, 15 in the chiropractor group therapy. The Hospital Anxiety and Depression Scale (HADS), The Patient Health Questionnaire 9-item (PHQ-9) and Generalized Anxiety Disorder 7- item scales (GAD-7) will be used as screening tools for depressive and anxiety symptoms respectively.

Description:

In this study, the objectives are to determine and compare the prevalence of symptoms of depression and anxiety and find the most effective treatment method to assist patients in improving their quality of life utilizing holistic health treatments such as acupuncture and chiropractic to support their physical and mental health. Depression and anxiety are currently a major public health challenge worldwide especially during the Covid-19 pandemic. Approximately 280 million people within the world have depression, and over 700,000 people die due to suicide per annum (WHO, 2021). This depression and anxiety in PLWHAs can result in poor quality of life, and quality of work, school, and family life. Also, risky sexual behavior, the spreading of the virus, and at its worst, depression can result in suicide. This controlled clinical trial will explore the treatment of acupuncture versus chiropractor care to seek out which treatment can help people living with HIV/AIDS (PLWH/A) to reduce depression and anxiety among PLWH/A patients in Being Alive, Los Angeles.

Recruitment information / eligibility

• Status: Enrolling by invitation
• Enrollment: 30
• Est. completion date: February 1, 2024
• Est. primary completion date: December 1, 2023
• Accepts healthy volunteers: No
• Gender: All
• Age group: N/A and older

Eligibility

Inclusion Criteria:

• single intervention only

Exclusion Criteria:

• chiropractic and acupuncture together

Related Conditions & MeSH terms

• Acquired Immunodeficiency Syndrome
• Anxiety Depression
• Anxiety Disorders
• Depression
• Depressive Disorder
• HIV Infections
• HIV/AIDS

Intervention

Other:
• Acupuncture
Acupuncture 1 time per month
• Chiropractic
Chiropractic 1 time per month

Locations

Country	Name	City	State
United States	Yo San University	Los Angeles	California

Sponsors (1)

Lead Sponsor	Collaborator
Yo San University of Traditional Chinese Medicine

Country where clinical trial is conducted

United States, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Hospital Anxiety and Depression Scale (HADS)	Seven item questionnaire of each anxiety and depression. The items are rated on 0, 1, 2, and 3 giving scores with minimum scores of 0 to 21 maximum. Score interpretation on anxiety or depression subscales ranging from 0-7 considered non case, 8-10 considered possible case, and 11-21 considered probable case, which have been reclassified and relabeled as follows: 0-7 normal, 8-10 = mild, 11-15= moderate, and =16 = severe of anxiety or depression.	3 months
Primary	The Patient Health Questionnaire 9-item (PHQ-9)	Patient Health Questionnaire for depression, score interpretation. Severity. The developers report the following interpretive guidelines for the PHQ-9 as a severity measure: 1-4 no depression, 5-9 = mild de- pression, 10-14= moderate depression, 15-19 = moderately severe depression, and 20-27= severe depression.	3 months
Primary	Generalized Anxiety Disorder 7-item (GAD-7)	Anxiety Disorder 7-item, scoring Scores of 5, 10, and 15 are taken as the cut-off points for mild, moderate, and severe anxiety, respectively.	3 months